Unassociated Document
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported) 
September 4, 2008
 
 
ALLIED HEALTHCARE PRODUCTS, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
(State or Other Jurisdiction
of Incorporation)
0-19266
(Commission
File Number)
25-1370721
(IRS Employer
Identification No.)

1720 Sublette Avenue, St. Louis, Missouri 
63110
(Address of principal executive offices) 
(Zip Code) 

Registrant’s telephone number, including area code 
(314) 771-2400
  
Not applicable
(Former name or former address, if changed since last report) 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o    Pre-commencement communications pursuant to Rule 13e-4© under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
 
On September 4, 2008, Registrant issued a press release announcing financial information for the quarter and year ended June 30, 2008. The press release is attached hereto as Exhibit 99.1 and is furnished to, but not filed with, the Commission.
 
ITEM 9.01 Financial Statements and Exhibits 
 
(c) Exhibits
 
Exhibit No. 
                   
Description 
99.1 
 
Press Release dated September 4, 2008 
 
 
 
 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.
 
Date: September 8, 2008
 
 
ALLIED HEALTHCARE PRODUCTS, INC. 
 
 
 
/s/ Daniel C. Dunn 
 
 
Daniel C. Dunn
 
Chief Financial Officer 
 
 
INDEX TO EXHIBITS
 
Exhibit No. 
                   
Description 
 
99.1 
 
Press Release dated September 4, 2008* 
 
*This exhibit is furnished to, but not filed with, the Commission by inclusion herein.